Cite

    C. Skrabs et al.. “Rapid decline in insulin antibodies and glutamic acid decarboxylase autoantibodies with ibrutinib therapy of chronic lymphocytic leukaemia.” Journal of clinical pharmacy and therapeutics, vol. 43, 2018, pp. 145–149. http://access.bl.uk/ark:/81055/vdc_100055530476.0x000043